Highly Efficient and Long-Lasting Chemiluminescence-Functionalized Nanohydrogel for Imaging-Guided Precise Piperlongumine Chemotherapy
A major challenge for imaging-guided precise chemotherapy remains the ability to track the in situ real-time variation of the reactive oxygen species (ROS) level during treatment with prooxidation antitumor drugs. Chemiluminescence (CL) is widely used as an <i>in vivo</i> imaging tool with an excellent signal-to-noise ratio and high biological safety. However, suffering from flash-type and poor water solubility, most of the reported CL probes for ROS detection are unsuitable for in vivo long-term tracking. Herein, we designed a water-soluble CL nanohydrogel (L-012/Co<sup>2+</sup>@NGs) by cross-linking of vinyl-derived β-cyclodextrin monomer (MAH-β-CD) and loaded with luminol analog L-012 and cobalt ions (Co<sup>2+</sup>). <i>In vitro</i> studies reveal that L-012/Co<sup>2+</sup>@NGs exhibit long-lasting CL emission (up to 4 h) due to the slow diffusion of hydrogen peroxide in the nanohydrogel. High catalytic efficiency from the accelerated reduction of Co<sup>3+</sup> to Co<sup>2+</sup> through Tris and chelation of Co<sup>2+</sup>, as well as protection of the β-CD cavity against the active intermediate of L-012, enables L-012/Co<sup>2+</sup>@NGs to exhibit a 722-fold CL signal turn-on ratio and a nanomolar limit of detection (8.9 nmol/L). Piperlongumine (PL) was selected as a model of prooxidation drugs. The long-term and highly efficient CL strategy was designed for monitoring the local dynamic changes of ROS in PL-treated tumor-bearing mice for 150 min. The CL signal increased over time until reaching its maximum with a ∼6-fold increase at 15 min and then decreased slowly. The CL-functionalized nanohydrogel platform with good biocompatibility offers a great opportunity for imaging-guided precise tumor chemotherapy of PL and other prooxidation antitumor drugs.
Authors
- Zhongxiang Chen (ORCID: https://orcid.org/0000-0003-0400-5004)
- Meiqin Li
- Haifeng Lu (ORCID: https://orcid.org/0000-0001-6484-6839)
- Miaomiao Zhang (ORCID: https://orcid.org/0000-0002-1797-9011)
- Yuting Li (ORCID: https://orcid.org/0000-0002-6716-358X)
- Kang Wang (ORCID: https://orcid.org/0000-0002-1451-2360)
- Qunlin Zhang (ORCID: https://orcid.org/0000-0002-7285-7893)
- Xun Fang (ORCID: https://orcid.org/0009-0006-7302-4662)
Institutions
- Anhui Medical University (CN)
Publication Details
- Journal
- Analytical Chemistry
- Published
- 2024-11-29
- DOI
- https://doi.org/10.1021/acs.analchem.4c05654
- Citations
- 4
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.74
Funders
- National Natural Science Foundation of China
- Anhui Medical University